Industry Briefs

A survey of the 100 biggest corporate spenders in research and development in the U.S. shows that they spent 10.7% more on R&D in 1988 than they did the year before. Inside R&D, a newsletter published in Englewood, N.J., by Technical Insights Inc., says that the biggest increase in spending was by Sun Microsystems Inc., which more than doubled its R&D effort, followed by Genentech Inc.’s 65.1% boost. The most massive R&D was led by General Motors which last year spent nearly $4.8 billion

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A survey of the 100 biggest corporate spenders in research and development in the U.S. shows that they spent 10.7% more on R&D in 1988 than they did the year before. Inside R&D, a newsletter published in Englewood, N.J., by Technical Insights Inc., says that the biggest increase in spending was by Sun Microsystems Inc., which more than doubled its R&D effort, followed by Genentech Inc.’s 65.1% boost. The most massive R&D was led by General Motors which last year spent nearly $4.8 billion on its scientists. In general, Inside R&D says, computer and pharmaceutical companies showed the most rapid growth. The newsletter added that corporate R&D needed the big increases just to keep up with the pace of corporate sales. Among the top 100, R&D actually dropped from 3.97% of sales in 1987 to 3.82% last year.

The General Accounting Office, reading to four recent proposals, has advised Congress ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies